JP2024510927A5 - - Google Patents

Info

Publication number
JP2024510927A5
JP2024510927A5 JP2023553029A JP2023553029A JP2024510927A5 JP 2024510927 A5 JP2024510927 A5 JP 2024510927A5 JP 2023553029 A JP2023553029 A JP 2023553029A JP 2023553029 A JP2023553029 A JP 2023553029A JP 2024510927 A5 JP2024510927 A5 JP 2024510927A5
Authority
JP
Japan
Prior art keywords
alkyl
exist
substituted
pabc
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023553029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510927A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/018534 external-priority patent/WO2022187370A1/en
Publication of JP2024510927A publication Critical patent/JP2024510927A/ja
Publication of JP2024510927A5 publication Critical patent/JP2024510927A5/ja
Pending legal-status Critical Current

Links

JP2023553029A 2021-03-03 2022-03-02 抗体-薬物コンジュゲートのための分岐リンカー及びその使用方法 Pending JP2024510927A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163156156P 2021-03-03 2021-03-03
US63/156,156 2021-03-03
US202163186581P 2021-05-10 2021-05-10
US63/186,581 2021-05-10
US202163214540P 2021-06-24 2021-06-24
US63/214,540 2021-06-24
US202163237450P 2021-08-26 2021-08-26
US63/237,450 2021-08-26
PCT/US2022/018534 WO2022187370A1 (en) 2021-03-03 2022-03-02 Branched linkers for antibody-drug conjugates and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024510927A JP2024510927A (ja) 2024-03-12
JP2024510927A5 true JP2024510927A5 (https=) 2025-03-06

Family

ID=83155529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023553029A Pending JP2024510927A (ja) 2021-03-03 2022-03-02 抗体-薬物コンジュゲートのための分岐リンカー及びその使用方法

Country Status (9)

Country Link
US (1) US20240148883A1 (https=)
EP (1) EP4301415A4 (https=)
JP (1) JP2024510927A (https=)
KR (1) KR20230165207A (https=)
AU (1) AU2022230398A1 (https=)
BR (1) BR112023017670A2 (https=)
CA (1) CA3210473A1 (https=)
MX (1) MX2023010099A (https=)
WO (1) WO2022187370A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121793989A (zh) * 2023-07-07 2026-04-03 索尔夫治疗公司 药物单元和靶向单元的缀合物及其前体化合物
WO2025080711A1 (en) * 2023-10-13 2025-04-17 Sutro Biopharma, Inc. Dual payload antibody drug conjugates
WO2025083071A2 (en) * 2023-10-16 2025-04-24 Hummingbird Bioscience Pte. Ltd. Antibody-drug conjugates
WO2025083069A1 (en) * 2023-10-16 2025-04-24 Hummingbird Bioscience Pte. Ltd. Her2-binding molecules
WO2026080692A1 (en) * 2024-10-09 2026-04-16 Sutro Biopharma, Inc. Branched beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9310374B2 (en) * 2012-11-16 2016-04-12 Redwood Bioscience, Inc. Hydrazinyl-indole compounds and methods for producing a conjugate
EP3373937B1 (en) * 2015-11-09 2021-12-22 R.P. Scherer Technologies, LLC Anti-cd22 antibody-maytansine conjugates and methods of use thereof
AU2016359230B2 (en) * 2015-11-25 2020-04-23 Ligachem Biosciences Inc. Conjugates comprising self-immolative groups and methods related thereto
JP7381478B2 (ja) * 2017-10-23 2023-11-15 マブリンク ビオシオンス 単一分子量ポリサルコシンを含むリガンド-薬物-複合体
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof
KR20200117992A (ko) * 2017-12-11 2020-10-14 트리페이스 리서치 앤드 디벨로프먼트 쓰리 코포레이션 항-cd22 항체-메이탄신 컨쥬게이트, 그것의 조합, 및 사용 방법
CN119896746A (zh) * 2019-01-23 2025-04-29 R.P.谢勒技术有限责任公司 用于抗体-药物缀合物的含有糖苷的肽接头
WO2022082397A1 (zh) * 2020-10-19 2022-04-28 江苏时代新能源科技有限公司 一种电池、用电装置及制备电池的方法、设备

Similar Documents

Publication Publication Date Title
JP2024510927A5 (https=)
ES2670017T3 (es) Molécula de ácido nucleico de cadena simple para el control de la expresión de genes
JP7403507B2 (ja) 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート
JP2022518743A5 (https=)
Sakai et al. Structure− activity relationships of the didemnins
CN101641372B (zh) 模板固定的肽模拟物
JP2021502120A5 (https=)
JP2022543231A5 (https=)
BG61485B1 (bg) N горе 4-оксикарбонил заместени 5'-деокси-5-флуороцитидини
CN102351931A (zh) 嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
JP2020525502A5 (https=)
JP2024529466A5 (https=)
JP2019501214A5 (https=)
CN114805212B (zh) 用于递送治疗或预防剂的脂质和脂质组合物
JP2023511184A5 (https=)
JP2024516613A5 (https=)
WO2024005460A1 (ko) 자가-희생기를 포함하는 화합물 및 이를 포함하는 리간드-약물 접합체
AU2007345099B2 (en) The tetracyclic anthraquinones possessing anti-cancer effect
JP2023551203A5 (https=)
US20120308646A1 (en) Tetracyclic anthraquinones possessing anti-cancer properties
CN112574273B (zh) 一类具有抗纤维化功能的三萜类化合物及其制备方法
Komatani et al. Solid-phase total synthesis of sandramycin and its analogues
JP2000309598A (ja) 多剤結合型新規化合物、その製造法および用途
JP2024532677A5 (https=)
CN104248770B (zh) 具有肿瘤导向性治疗作用的多肽‑药物缀合物及其应用